Search

14/04/2023 Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI
Redondo, S, Garcia-Cadenas, I, Vila, A, Esquirol, A, Portos, JM, Novelli, S, Saavedra, S, Moreno, C, Garrido, A, Arguello-Tomas, M, Onate, G, Lopez-Pardo, J, Caballero, AC, Miqueleiz, S, Briones, J, Sierra, J, Sancho, G, Martino, R. Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI. EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; 111(1)DOI:10.1111/ejh.13978. PMID:37058419. IF:2.300(Q2/5D).
01/04/2023 Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus
Bonet, M, Gonzalez, D, Baquedano, JE, Garcia, E, Altabas, M, Casas, F, Feltes, N, Ferrer, F, Foro, P, Fuentes, R, Galdeano, M, Gomez, D, Henriquez, I, Jove, J, Lozano, J, Maldonado, X, Mases, J, Membrive, I, Paredes, S, Rosello, A, Sancho, G, Mira, M. Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus. Clinical & Translational Oncology. 2023; 25(4)DOI:10.1007/s12094-022-03005-4. PMID:36436177. IF:2.800(Q2/5D).
01/01/2023 Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
Pérez-Fidalgo J.A., Ortega E., Ponce J., Redondo A., Sevilla I., Valverde C., Verdum, JI, de Alava E., Lopez, MG, Marquina G., Sebio A.. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). Therapeutic Advances in Medical Oncology. 2023; 15DOI:10.1177/17588359231157645. PMID:37007636. IF:4.300(Q2/3D).
01/11/2022 Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy
Camacho, M, Leon, X, Pujol, A, Montezuma, L, Quer, M, Garcia, J. Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy. Clinical & Translational Oncology. 2022; 24(11)DOI:10.1007/s12094-022-02870-3. PMID:35752749. IF:3.400(Q3/6D).
01/08/2022 Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group
Eraso, A, Sanz, J, Molla, M, Reyes, V, Pedro, A, Arenas, M, Martinez, E, Ballester, R, Cambra, MJ, Garcia, V, Prades, JL, Borras, JM, Algara, M. Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group. Clinical & Translational Oncology. 2022; 24(8)DOI:10.1007/s12094-022-02798-8. PMID:35190961. IF:3.400(Q3/6D).
22/07/2022 Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study
Suarez, JF, Zamora, V, Garin, O, Gutierrez, C, Pont, A, Pardo, Y, Goni, A, Marino, A, Hervas, A, Herruzo, I, Cabrera, P, Sancho, G, de Leon, JP, Macias, V, Guedea, F, Vigues, F, Castells, M, Ferrer, M. Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-16395-w. PMID:35869124. IF:4.600(Q2/4D).
14/07/2022 Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
Lara, PC, Rodriguez-Melcon, JI, Palacios-Eito, A, Lozano, A, Hervas-Moron, A, Villafranca, E, Gomez-Iturriaga, A, Sancho, G, Maldonado, X. Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer. Frontiers in Oncology. 2022; 12DOI:10.3389/fonc.2022.891886. PMID:35912190. IF:4.700(Q2/4D).
01/06/2022 Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Rodríguez F., Caruana P., De la Fuente N., Español P., Gámez M., Balart J., Llurba E., Rovira R., Ruiz R., Martín-Lorente C., Corchero J.L., Céspedes M.V.. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges. Biomolecules. 2022; 12(6)DOI:10.3390/biom12060784. PMID:35740909. IF:5.500(Q1/3D).
01/11/2021 Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy
Leon, X, Garcia, J, Farre, N, Majercakova, K, Aviles-Jurado, FX, Quer, M, Camacho, M. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy. Acta Otorrinolaringologica Espanola. 2021; 72(6)DOI:10.1016/j.otorri.2020.05.003. PMID:32972719. IF:(Q/D).
01/10/2021 Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study
de Dios, NR, Counago, F, Murcia-Mejia, M, Rico-Oses, M, Calvo-Crespo, P, Samper, P, Vallejo, C, Luna, J, Trueba, I, Sotoca, A, Cigarral, C, Farre, N, Manero, RM, Duran, X, Gispert, JD, Sanchez-Benavides, G, Rognoni, T, Torrente, M, Capellades, J, Jimenez, M, Cabada, T, Blanco, M, Alonso, A, Martinez-San Millan, J, Escribano, J, Gonzalez, B, Lopez-Guerra, JL. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study. JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(28)DOI:10.1200/JCO.21.00639. PMID:34379442. IF:50.739(Q1/1D).
01/09/2021 Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment
Lozano, A, Marruecos, J, Rubio, J, Farre, N, Gomez-Millan, J, Morera, R, Planas, I, Lanzuela, M, Vazquez-Masedo, MG, Cascallar, L, Giralt, J, Escames, G, Valenti, V, Grima, P, Bosser, R, Tarrago, C, Mesia, R. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment. Clinical & Translational Oncology. 2021; 23(9)DOI:10.1007/s12094-021-02586-w. PMID:33738704. IF:3.340(Q3/7D).
01/08/2021 Impact of covid-19 on patients in radiotherapy oncology departaments in Spain
Ots, PMS, Ortuno, JZ, Fernandez, SP, Canellas, EM, San Segundo, CG, Vargas, MC, Caballero, B, Albiac, MR, Masedo, GV, Alvarez, B, Villalba, SR, Miguelanez, TM, Garcia, PD, Sancho, G, Gomez, LG, Tripero, J, Oses, MRR, Villoslada, CI, Rodriguez, AMSS, Chust, ML, Soler, AF, Martin, EML, Macias, VM, Sanchez, CF, Moya, LT, Lopez, JF, Sole, JM, Verdu, MG, Flores, MM, Wals, A, Hernandez, JE. Impact of covid-19 on patients in radiotherapy oncology departaments in Spain. RADIOTHERAPY AND ONCOLOGY. 2021; 161DOI:10.1016/j.radonc.2021.06.001. PMID:34118358. IF:6.901(Q1/2D).
01/07/2021 Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study
Garin, O, Suarez, JF, Guedea, F, Pont, A, Pardo, Y, Goni, A, Marino, A, Hervas, A, Herruzo, I, Cabrera, P, Sancho, G, de Leon, JP, Macias, V, Gutierrez, C, Castells, M, Ferrer, M. Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2021; 110(3)DOI:10.1016/j.ijrobp.2020.12.032. PMID:33388360. IF:8.013(Q1/1D).
01/09/2025 Is SBRT the optimal first-line treatment for operable early-stage NSCLC in elderly patients?
Soto-Cambres, AM, Farré, N. Is SBRT the optimal first-line treatment for operable early-stage NSCLC in elderly patients?. Clinical & Translational Oncology. 2025; 27(9)DOI:10.1007/s12094-025-03914-0. PMID:40221951. IF:2.500(Q3/6D).
01/09/2025 Duration of androgen deprivation therapy with salvage radiotherapy in patients with prostate cancer and biochemical recurrence after surgery: Initial recruitment data in the phase III URONCOR 06-24 trial
Segundo, CGS, López-Campos, F, Iturriaga, AG, Santos, M, Ocanto, A, Montezuma, L, Boladeras-Inglada, AM, Glaria, L, Guardado, S, Rodríguez, A, Henríquez, I, Olivera, J, Duque-Santana, V, Garre, J, Moreno, S, Valero, J, Conde, AJ, Doval, A, Sancho, G, Nieto, PM, Cantos, AC, García, N, Alonso, SF, García, RG, Gavela, AD, Buchser, D, Maldonado, X, Mases, J, Requejo, OH, Sanmamed, N, Salamanca, JIM, Couñago, F. Duration of androgen deprivation therapy with salvage radiotherapy in patients with prostate cancer and biochemical recurrence after surgery: Initial recruitment data in the phase III URONCOR 06-24 trial. Actas Urologicas Espanolas. 2025; 49(7)DOI:10.1016/j.acuro.2025.501823. PMID:. IF:1.200(Q3/7D).
01/08/2025 Transplantation of a healthy bone marrow into hypertriglyceridemic animals improves liver metabolism and favours cardiac healing post-myocardial infarction
Ramos-Regalado, L, Alcover, S, Padró, T, Sancho, G, Badimon, L, Balart, J, Vilahur, G. Transplantation of a healthy bone marrow into hypertriglyceridemic animals improves liver metabolism and favours cardiac healing post-myocardial infarction. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/05/2025 Different scenarios of radiotherapy in CAR T-cell therapy: A single Institution experience
Piedra-Argudo, M, Rojas-Cordero, J, Julia-Sahuja, J, Vila-Capel, A, Bermejo-Martinez, S, Rabi-Mitre, S, Crespo-Perez, S, Calvet-Molinas, G, Majercakova, K, Ejimeno-Castejon, A, Sopena-Carrera, B, Sancho-Pardo, G. Different scenarios of radiotherapy in CAR T-cell therapy: A single Institution experience. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).
01/01/2024 Swallowing muscle training for oropharyngeal dysphagia: A non-inferiority study of online versus face-to-face therapy
Bascunana-Ambros, H, Renom-Guiteras, M, Nadal-Castells, MJ, Beranuy-Rodriguez, M, Perrot-Gonzalez, JC, Ramirez-Mirabal, E, Trejo-Omenaca, A, Monguet-Fierro, JM. Swallowing muscle training for oropharyngeal dysphagia: A non-inferiority study of online versus face-to-face therapy. JOURNAL OF TELEMEDICINE AND TELECARE. 2024; 30(1)DOI:10.1177/1357633X211035033. PMID:34355589. IF:3.200(Q2/3D).
01/05/2023 Influence on Therapeutic Decision-Making of Supine and Standing Radiographs after Traumatic Thoracolumbar Fracture in the Elderly
Noguera-Alonso, L, Vila-Canet, G, De Caso-Rodriguez, J, Da Ponte-Prieto, A, Perez-Romera, AB, Velazquez-Fragoso, JJ. Influence on Therapeutic Decision-Making of Supine and Standing Radiographs after Traumatic Thoracolumbar Fracture in the Elderly. Journal of Neurological Surgery Part A-Central European Neurosurgery. 2023; 84(3)DOI:10.1055/s-0042-1753514. PMID:36100237. IF:0.900(Q3/8D).
01/12/2022 Early Postoperative CT Scan Provides Prognostic Data on Clinical Outcomes of Fresh Osteochondral Transplantation of the Knee
Gelber, PE, Ramirez-Bermejo, E, Farinas, O. Early Postoperative CT Scan Provides Prognostic Data on Clinical Outcomes of Fresh Osteochondral Transplantation of the Knee. AMERICAN JOURNAL OF SPORTS MEDICINE. 2022; 50(14)DOI:10.1177/03635465221129601. PMID:36322380. IF:4.800(Q1/1D).